Inactive Instrument

News Carl Zeiss Meditec AG Other OTC

Equities

Goldman downgrades Carl Zeiss Meditec to 'Sell' - Target 90 euros	May. 23	DP
CARL ZEISS MEDITEC AG : Downgraded from Neutral to Sell by Goldman Sachs	May. 23	ZD
CARL ZEISS MEDITEC AG : Downgraded to Sell by Goldman Sachs	May. 23	ZD
Ailing hospitals slow down German medical technology sector	May. 23	DP
CARL ZEISS MEDITEC AG : JP Morgan reiterates its Sell rating	May. 22	ZD
CARL ZEISS MEDITEC AG : RBC gives a Buy rating	May. 21	ZD
CARL ZEISS MEDITEC AG : Receives a Buy rating from UBS	May. 16	ZD
CARL ZEISS MEDITEC AG : Hauck & Aufhauser gives a Buy rating	May. 10	ZD
CARL ZEISS MEDITEC AG : Deutsche Bank sticks Neutral	May. 09	ZD
CARL ZEISS MEDITEC AG : JP Morgan keeps a Sell rating	May. 09	ZD
CARL ZEISS MEDITEC : Weaker-than-expected Q2 + lacklustre guidance	May. 08
CARL ZEISS MEDITEC AG : RBC remains its Buy rating	May. 08	ZD
CARL ZEISS MEDITEC AG : Berenberg remains Neutral	May. 08	ZD
CARL ZEISS MEDITEC AG : JP Morgan keeps a Sell rating	May. 08	ZD
CARL ZEISS MEDITEC AG : UBS maintains a Buy rating	May. 08	ZD
Jenoptik with jump in profits in first quarter - share price rises	May. 08	DP
U.S. Futures Mixed, European Stocks Rise	May. 08	DJ
Transcript : Carl Zeiss Meditec AG, H1 2024 Earnings Call, May 08, 2024	May. 08
Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects	May. 08	EQ
AFR: Carl Zeiss Meditec AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	Apr. 30	EQ

No results for this search

CARL ZEISS MEDITEC : Weaker-than-expected Q2 + lacklustre guidance

May 08, 2024 at 09:28 am EDT